Trial intelligence / Profile preview

Yinzhihuang Oral Liquid for Neonatal Hyperbilirubinemia with G6PD Deficiency

NCT02594904Phase 4Unknown

Sponsor
Southern Medical University
Start
Jul 2015
Primary completion
Apr 2016
Modality
PE (Plant Extract)
Countries
1
01

Overview

A Phase 4 trial of yinzhihuang in neonatal hyperbilirubinemia, sponsored by Southern Medical University. Status: unknown.

02

Drugs

yinzhihuang
03

Conditions

neonatal hyperbilirubinemia

Beyond the preview

Go deeper on NCT02594904.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02594904.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call